Evidence of cannabinoid modulation in nuclear signaling
; Giusto, Norma Maria
; Pasquaré, Susana Juana Fecha
2019
Editorial
Fundación Revista Medicina
Revista
Título del libro
Nombre del evento
LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica ; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental ; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología ; IX Reunión Anual de la Asociación Argentina de Nanomedicinas; VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Fecha del evento
2019-11-13
Institución organizadora
Sociedad Argentina de Investigación Clínica
Asociación Argentina de Farmacología Experimental
Sociedad Argentina de Biología
Sociedad Argentina de Protozoología
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
The Histochemical Society
Asociación Argentina de Farmacología Experimental
Sociedad Argentina de Biología
Sociedad Argentina de Protozoología
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
The Histochemical Society
ISSN
0025-7680
eISSN
1669-9106
ISBN
Idioma
Inglés
Tipo del evento
Reunión
Clasificación temática
Palabras clave
Resumen
The endocannabinoid system (ECS) is a signaling mechanism involved in many pathophysiological processes, especially in the nervous system. Former studies from our lab demonstrated the presence of the different components of the ECS in nuclei from rat cerebellum and cerebral cortex (CC). We detected diacylglycerol lipase and monoacylglycerol lipase activities which are involved in maintaining the levels of the endocannabinoid 2-arachidonoyl-glycerol. In addition, we demonstrated a nuclear CB1 protein expression by Western Blot and immunocytochemistry. CB1 is a GPCR receptor that triggers different signaling cascades, modulating intracellular Ca²+ levels, ERK1/2 phosphorylation, and other second messengers at the plasma membrane. Nevertheless, we also observed an increase in ERK phosphorylation in isolated nuclei from rat cerebral cortex (CCN) incubated with a CB1 synthetic agonist (WIN 55-212-2). Phosphorylated ERK could be involved in activating MSK1/2, a nuclear kinase that phosphorylates histone 3 (H3). The aim of this work was therefore to study how a cannabinoid agonist modulates ERK1/2 and H3 phosphorylation in CCN. To this end, CC from Wistar rats were dissected and homogenized, and highly purified nuclei (CCN) were isolated on a sucrose-density ultracentrifugation. CCN were subsequently incubated at 37 °C with WIN and ERK1/2 and H3 signaling cascades were studied by Western Blot. Interestingly, it was observed that ERK1/2 and H3 phosphorylation increased in nuclei treated with WIN 5 µM for 30 min with respect to controls (p<0.05). As expected, this was reversed by pre-incubating for 10 min with a MEK inhibitor (U0126, 10 µM), however, no changes were observed when a CB1 antagonist (SR141716, 1 µM) was used (p<0.05). Taken together, these results demonstrate that cannabinoids at nuclear level could modulate H3 phosphorylation by ERK1/2 signaling. This indicates a potential role of these lipids in chromatin regulation and gene expression in cerebral cortex
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
